Stories > Autolus Thrives with $350M Offering and Strategic Collaborations

Autolus Thrives with $350M Offering and Strategic Collaborations

BCMA-Targeted CAR-T Cell Therapy Progres...

AB-2100 Phase 1/2 Trial Initiated

AI-Powered Cancer Drug Trials

Abeona Therapeutics Grants Inducement Aw...